Smallwood R H, Morgan D J, Mihaly G W, Jones D B, Smallwood R A
Victorian College of Pharmacy, Melbourne, Australia.
J Pharmacokinet Biopharm. 1988 Aug;16(4):377-96. doi: 10.1007/BF01062552.
In the past, various models have been developed to allow better characterization of the hepatic elimination of substrates from plasma. In this study we investigated the applicability of the venous equilibrium, undistributed sinusoidal, several distributed sinusoidal, and dispersion models to the steady state elimination of sodium taurocholate by the isolated perfused rat liver. Rat livers were perfused with 24-14C-taurocholate (sodium salt) at a concentration of 25 microM (specific activity 500 microCi/mmole) in a single-pass design (n = 7) or at a rate of 0.5 mumol/min (specific activity 40 microCi/mmole) into the portal vein in a recirculating design (n = 5). In single-pass experiments, the changes in hepatic venous outflow concentration (C0) with changes in unbound fraction of taurocholate (fu) from 0.09 to 1.0 were fitted better by the venous equilibrium model, by the dispersion model, and by a distributed model in which heterogeneity in both hepatic blood flow (Q) and intrinsic clearance (CLint) was defined by separate density functions. The very large value of dispersion number (DN greater than 10(7] yielded by the dispersion model is consistent with a high degree of axial mixing of blood within sinusoids. The large coefficients of variation (0.7-232) for the density functions describing the transverse heterogeneity of Q and CLint obtained with the Q/CLint-distributed model were consistent with a large degree of heterogeneity in Q and CLint within the liver. In recirculation experiments, the steady state unbound concentration of taurocholate in the reservoir (Cuss) was independent of fu (range 0.05-0.9). This finding was not predicted by the undistributed sinusoidal model, but was in keeping with the venous equilibrium model, with the dispersion model, and with the Q/CLint-distributed model. Therefore, there is no need to invoke cell surface-mediated dissociation of albumin-ligand complexes in hepatic taurocholate uptake. As the dispersion and Q/CLint-distributed models are conceptually plausible and operationally accurate, it may be time to relinquish the venous equilibrium model, which, though operationally accurate, is conceptually flawed.
过去,人们开发了各种模型以更好地表征血浆中底物的肝脏清除情况。在本研究中,我们研究了静脉平衡模型、非分布性肝血窦模型、几种分布性肝血窦模型以及弥散模型在离体灌注大鼠肝脏对牛磺胆酸钠稳态清除中的适用性。大鼠肝脏在单通道设计(n = 7)中以25 μM(比活度500 μCi/mmole)的浓度用24-¹⁴C-牛磺胆酸钠(钠盐)灌注,或在循环设计(n = 5)中以0.5 μmol/min(比活度40 μCi/mmole)的速率注入门静脉。在单通道实验中,当牛磺胆酸钠的未结合分数(fu)从0.09变化到1.0时,肝脏静脉流出浓度(C0)的变化用静脉平衡模型、弥散模型以及一个通过单独密度函数定义肝血流(Q)和内在清除率(CLint)异质性的分布模型拟合效果更好。弥散模型得出的非常大的弥散数(DN大于10⁷)与肝血窦内血液的高度轴向混合一致。用Q/CLint分布模型获得的描述Q和CLint横向异质性的密度函数的大变异系数(0.7 - 232)与肝脏内Q和CLint的高度异质性一致。在循环实验中,储液器中牛磺胆酸钠的稳态未结合浓度(Cuss)与fu无关(范围0.05 - 0.9)。这一发现未被非分布性肝血窦模型预测到,但与静脉平衡模型、弥散模型以及Q/CLint分布模型一致。因此,在肝脏摄取牛磺胆酸钠过程中无需引入白蛋白 - 配体复合物的细胞表面介导解离。由于弥散模型和Q/CLint分布模型在概念上合理且操作准确,或许是时候放弃静脉平衡模型了,尽管它操作准确,但在概念上存在缺陷。